World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
46
Citations
6858
World Ranking
16146
National Ranking
4021

Stefano Costanzi publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Stefano Costanzi sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 166 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Stefano Costanzi D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Stefano Costanzi sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 46 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Stefano Costanzi is affiliated with the American University in the United States and has an extensive publication record focused primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work intersects several subfields including Organic Chemistry, Molecular Biology, Physiology, Computational Theory and Mathematics, and Rheumatology.

The research topics addressed by Costanzi emphasize Adenosine and Purinergic Signaling, Computational Drug Discovery Methods, and Receptor Mechanisms and Signaling. Additional areas of study include Chemistry and Chemical Engineering, Monoclonal and Polyclonal Antibodies Research, Neuropeptides and Animal Physiology, and Bacillus and Francisella bacterial research.

Costanzi's recent published papers span diverse but interrelated scientific domains. Notable papers include:

  • Chemical Warfare Agents, 2020, Kirk-Othmer Encyclopedia of Chemical Technology
  • Lists of Chemical Warfare Agents and Precursors from International Nonproliferation Frameworks: Structural Annotation and Chemical Fingerprint Analysis, 2020, Journal of Chemical Information and Modeling
  • GPR101: Modeling a constitutively active receptor linked to X-linked acrogigantism, 2023, Journal of Molecular Graphics and Modelling
  • Strengthening controls on Novichoks: a family-based approach to covering A-series agents and precursors under the chemical-weapons nonproliferation regime, 2021, The Nonproliferation Review

The frequent coauthors with whom Costanzi has collaborated include Kenneth A. Jacobson, T. Kendall Harden, Giuseppe Grandaliano, Gregory D. Koblentz, and Gisella Vischini. These collaborations highlight interdisciplinary and cross-institutional research efforts.

Costanzi's papers have been published repeatedly in venues such as UNC Libraries, Annals of the Rheumatic Diseases, Nephrology Dialysis Transplantation, Pure and Applied Chemistry, and the Journal of Chemical Information and Modeling. This distribution reflects a broad engagement with journals covering rheumatology, chemistry, and biomedical informatics.

Overall, Stefano Costanzi's research contributions focus on advancing understanding in molecular signaling pathways, chemical warfare agent analysis, and therapeutic strategies within medicine and chemical sciences. The work demonstrates a blend of experimental, computational, and theoretical approaches across a range of biomedical and chemical disciplines.

Best Publications

  • Adenosine deaminase: Functional implications and different classes of inhibitors

    Gloria Cristalli;Stefano Costanzi;Catia Lambertucci;Giulio Lupidi

  • Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation

    Giampaolo Trivellin;Adrian F. Daly;Fabio R. Faucz;Bo Yuan

  • Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008

    Mayako Michino;Enrique Abola;Charles L. Brooks;J. Scott Dixon

  • Low level exposure to cadmium increases the risk of chronic kidney disease: analysis of the NHANES 1999-2006

    Pietro Manuel Ferraro;Stefano Costanzi;Alessandro Naticchia;Antonio Sturniolo

  • Nerve Agents: What They Are, How They Work, How to Counter Them.

    Stefano Costanzi;John-Hanson Machado;Moriah Mitchell

  • On the Applicability of GPCR Homology Models to Computer-Aided Drug Discovery: A Comparison between In Silico and Crystal Structures of the β2-Adrenergic Receptor

    Stefano Costanzi

  • Examining the Chirality, Conformation and Selective Kinase Inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550)

    Jian-kang Jiang;Kamran Ghoreschi;Francesca Deflorian;Zhi Chen

  • Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling.

    Stefano Costanzi;Liaman Mamedova;Zhan-Guo Gao;Kenneth A. Jacobson

  • Discovery of novel Agonists and antagonists of the free fatty acid receptor 1 (FFAR1) using virtual screening

    Irina G. Tikhonova;Chi Shing Sum;Susanne Neumann;Stanislav Engel

  • Prediction of passive blood-brain partitioning: straightforward and effective classification models based on in silico derived physicochemical descriptors.

    Santiago Vilar;Mayukh Chakrabarti;Stefano Costanzi

  • Allosteric "beta-blocker" isolated from a DNA-encoded small molecule library.

    Seungkirl Ahn;Alem W. Kahsai;Biswaranjan Pani;Qin-Ting Wang

  • Identification of Residues Important for Agonist Recognition and Activation in GPR40

    Chi Shing Sum;Irina G. Tikhonova;Susanne Neumann;Stanislav Engel

  • A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone/chorionic gonadotropin receptor (LHCGR).

    Holger Jäschke;Holger Jäschke;Susanne Neumann;Susanna Moore;Craig J. Thomas

  • N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands.

    Rosaria Volpini;Stefano Costanzi;Catia Lambertucci;Sara Taffi

  • Synthesis and biological activity of a new series of N6-arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-carboxamido derivatives of adenosine-5'-N-ethyluronamide as A1 and A3 adenosine receptor agonists.

    Baraldi Pg;Cacciari B;Pineda de Las Infantas Mj;Romagnoli R

  • New substituted 9-alkylpurines as adenosine receptor ligands

    Emidio Camaioni;Stefano Costanzi;Sauro Vittori;Rosaria Volpini

  • A2B adenosine receptor blockade inhibits growth of prostate cancer cells

    Qiang Wei;Stefano Costanzi;Ramachandran Balasubramanian;Zhan-Guo Gao

  • A low-molecular-weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism.

    Susanne Neumann;Gunnar Kleinau;Stefano Costanzi;Susanna Moore

  • Evaluation of Small Molecule Modulators of the Luteinizing Hormone/Choriogonadotropin and Thyroid Stimulating Hormone Receptors: Structure Activity Relationships and Selective Binding Patterns

    Susanna Moore;Holger Jaeschke;Gunnar Kleinau;Susanne Neumann

  • Human P2Y6 Receptor: Molecular Modeling Leads to the Rational Design of a Novel Agonist Based on a Unique Conformational Preference

    Stefano Costanzi;Bhalchandra V. Joshi;Savitri Maddileti;Liaman Mamedova

  • Medicinal chemistry and pharmacology of A2B adenosine receptors.

    Rosaria Volpini;Stefano Costanzi;Sauro Vittori;Gloria Cristalli

  • Bidirectional, iterative approach to the structural delineation of the functional "chemoprint" in GPR40 for agonist recognition.

    Irina G. Tikhonova;Chi Shing Sum;Susanne Neumann;Craig J. Thomas

Frequent Co-Authors

Sauro Vittori
Sauro Vittori University of Camerino
Kenneth A. Jacobson
Kenneth A. Jacobson National Institutes of Health
Karl-Norbert Klotz
Karl-Norbert Klotz University of Würzburg
Marvin C. Gershengorn
Marvin C. Gershengorn National Institutes of Health
Jürgen Wess
Jürgen Wess National Institutes of Health
T. Kendall Harden
T. Kendall Harden University of North Carolina at Chapel Hill
Craig J. Thomas
Craig J. Thomas National Institutes of Health
Zhan-Guo Gao
Zhan-Guo Gao National Institutes of Health
Stanko S. Stojilkovic
Stanko S. Stojilkovic National Institutes of Health
Albert Beckers
Albert Beckers University of Liège

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Chemistry, exploring related fields such as forensic science and criminal justice can open up diverse career opportunities. Pursuing an online masters forensic psychology is one option that complements scientific knowledge with behavioral analysis, especially in legal contexts.

Careers in forensic science offer practical applications of chemistry in crime labs, toxicology, and evidence analysis. Understanding these pathways can help students tailor their studies towards specialized roles. For a broader look at this field, check out information on careers in forensic science.

Financial considerations are also important when selecting a degree. Learning about how much does a criminal justice degree cost provides valuable insight into planning education budgets.

Additionally, starting with a foundational qualification like a criminal justice associate degree online can be a cost-effective approach to entering the field before advancing to higher-level programs.

Best Scientists Citing Stefano Costanzi

Trending Scientists

Recently Published Articles